Europe Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth

Europe Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth

Summary

GlobalData’s “Europe Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth” report is an essential source of data and analysis on the Europe coronary stents market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories – bare metal stents and drug eluting stents. The report identifies the key trends shaping and driving the dynamism in the Europe coronary stents market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Europe coronary stents market.

Scope

- The report provides market size data and information on two Europe coronary stents market categories – bare metal stents and drug eluting stents.
- Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
- Analysis and review of the key events and milestones that will impact the future of the Europe coronary stents market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the Europe coronary stents market in the long run.
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the Europe coronary stents Market.
- Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the Europe coronary stents market in future.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- What’s the next being thing in the Europe coronary stents technology landscape? – Identify, understand and capitalize.

1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Executive Summary 7
3 Coronary Stents Market Overview 8
3.1 Introduction and Definition 8
3.1.1 Coronary Stents 8
3.1.1.1 Bare Metal Stents 8
3.1.1.2 Drug Eluting Coronary Stents 8
3.2 Market Overview 9
3.2.1 Risk Factors for Coronary Disease 12
3.2.2 Conditions Required for Stenting 12
3.3 Cross Category Analysis 13
3.3.1 Europe Interventional Cardiology Market Cross Category Analysis (2001-2015) 13
3.4 Competitive Landscape 14
3.5 The Europe Coronary Stent Market: Trend Analysis 16
3.5.1 Market Snapshot 16
3.5.2 Emergence of DES - Overview 16
3.5.2.1 Drug Eluting Stent (DES) Market: Drivers 17
3.5.2.2 Drug Eluting Stent (DES) Market: Restraints 18
3.5.3 Stent Coatings 18
3.5.4 Stent Implantation Procedure – Overview 19
3.5.5 Key End Users 20
3.5.6 The Europe Coronary Stent Market: Key Challenges 20
3.5.7 The Europe Coronary Stent Market: Drivers 20
3.5.7.1 Developments in Imaging: Enhanced Accuracy of Implantation and Surgical Procedures 21
3.5.7.2 Increased obesity rates in some population groups enhances the demand for Percutaneous Coronary Intervention (PCI) 21
3.5.7.3 Affordability of BMS drives the growth for stenting procedures in Europe 21
3.5.7.4 Minimally invasive surgery increasing demand for overall stenting procedures 21
3.5.7.5 The Next Generation of Hybrid Devices Could Increase Treatment Outcome and Device Applicability 22
3.5.7.6 Growing patient awareness drives uptake for overall stenting procedures 22
3.5.8 The Europe Coronary Stent Market: Restraints 22
3.5.8.1 Alternative treatment options creating a threat to the usage of coronary stents 22
3.5.8.2 Negative Publicity Related To Stent Market Have Affected the Usage of DES 22
3.5.8.3 Consolidation of the Market Creates Barriers to Entry for Small Companies Limiting Growth 23
3.5.9 Emerging Technologies in the Europe Coronary Stent Market 24
3.5.9.1 Diamond like Carbon Coating (DLC) 24
3.5.9.2 Advanced Drug eluting coatings 24
3.5.9.3 Bioabsorbable Stents 24
3.5.9.4 Platinum Enriched Stainless Steel (PERSE) 26
3.5.9.5 Antibody coated or gene therapy stents 26
3.6 Future Outlook and Implications: Europe Coronary Stent Market 26
4 Mergers & Acquisitions 27
4.1 Mergers & Acquisitions in 2009 27
4.1.1 Boston Scientific Acquires Labcoat 27
4.2 Mergers & Acquisitions in 2007 27
4.2.1 Medtronic Acquires Setagon 27
4.3 Mergers & Acquisitions in 2006 27
4.3.1 Abbott Laboratories Acquires Vascular Business of Guidant From Boston Scientific 27
5 Coronary Stent Pipeline Products: Europe 28
5.1 Key Coronary Stent pipeline products 28
6 Appendix 39
6.1 Research Methodology 39
6.2 Coverage 40
6.3 Secondary Research 41
6.4 Primary Research 41
6.5 Models 42
6.6 Forecasts 42
6.7 Expert Panels 42
6.8 GlobalData Consulting 43
6.9 Contact Us 43
6.10 Disclaimer 43

1.1 List of Tables
Table 1: Coronary Stent Market, Europe, Overall Revenue ($ mn), Historic, 2001 – 2008 11
Table 2: Coronary Stent Market, Europe, Overall Revenue ($ mn), Forecast, 2008 – 2015 12
Table 3: Company Share in the Europe Coronary Stent Market ($ mn) and (%), 2007 15
Table 4: Drug-Eluting Stents Comparison 17
Table 5: Coatings on Drug Eluting Stents 19
Table 6: Key Companies with Bioabsorbable Stents in Pipeline 25
Table 7: Coronary Stent Pipeline Products By Equipment Type 28
Table 8: Coronary Stent Pipeline Products By Development Stage 30
Table 9: Coronary Stent Pipeline Products By Therapy Area 33

1.2 List of Figures
Figure 1: Coronary Stents Market Definition, Europe, 2008 8
Figure 2: Segment Contribution By Type Of Coronary Stent (%), Europe, 2008 10
Figure 3: Coronary Stent Market, Europe, Overall Revenue ($ mn), 2001 – 2015 11
Figure 4: Europe Interventional Cardiology Market Cross Category Analysis (2001-2015) 13
Figure 5: Company Share in the Europe Coronary Stent Market (%), 2007 14
Figure 6: History of Coronary Artery Disease Prevention, Europe, 2008 16
Figure 7: Diagrammatic Representation of Artery Before and After Placing the Stent 20
Figure 8: Drivers and Restraints in the Europe Coronary Stent Market 23
Figure 9: GlobalData Methodology 40